Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

• Status: Withdrawn
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five years after their completion of study participation in protocol VTI-206 (NCT00973817) to gather information relating to the incidence of liver transplant, the incidence and type of cancer (if any), and survival.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vital Therapies, Inc.

Criteria

Inclusion Criteria:

• Subjects participating in the VTI-206 clinical trial.

Exclusion Criteria:

• Subjects not participating in the VTI-206 clinical trial.